Intuitive Surgical, Inc. $ISRG Stock: Waycross Partners LLC Raises Position

Waycross Partners LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.6% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 71,310 shares of the medical equipment provider’s stock after purchasing an additional 7,397 shares during the period. Intuitive Surgical comprises about 2.2% of Waycross Partners LLC’s investment portfolio, making the stock its 21st biggest holding. Waycross Partners LLC’s holdings in Intuitive Surgical were worth $28,997,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of America Corp DE raised its stake in Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after purchasing an additional 116,292 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Intuitive Surgical in the second quarter worth $1,335,753,000. Amundi boosted its position in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after buying an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after buying an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Intuitive Surgical by 10.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after buying an additional 184,044 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $15.72 during mid-day trading on Friday, reaching $452.80. The company had a trading volume of 2,150,343 shares, compared to its average volume of 2,506,658. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The stock has a market capitalization of $156.96 billion, a PE ratio of 54.75, a price-to-earnings-growth ratio of 3.01 and a beta of 1.45. The stock’s 50 day moving average is $409.93 and its 200-day moving average is $431.89.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter last year, the firm earned $2.40 earnings per share. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. TD Cowen reissued a “buy” rating and set a $485.00 price target on shares of Intuitive Surgical in a research report on Monday, October 19th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Wednesday, October 21st. Leerink Partners set a $503.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 21st. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $493.54.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Insider Buying and Selling

In related news, Director Gary S. Guthart sold 20,095 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the sale, the director owned 1,204,530 shares of the company’s stock, valued at approximately $543,977,793.30. The trade was a 1.64% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the transaction, the vice president owned 1,026 shares in the company, valued at $464,993.46. This represents a 79.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 49,928 shares of company stock worth $21,917,367. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile